๐ค Intuitive Surgical $ISRG craters ~10% despite big earnings beat โ da Vinci growth slows
ISRG crushed Q2 estimates โ revenue up 18.5% YoY, EPS up 26.5%, and da Vinci installations now at 11,710 units globally. But management guided full-year procedure growth down to ~14%, stepping back from 18% in 2025, and the market punished it hard. Classic case of beating estimates but failing to beat expectations. Not financial advice. Do you think this dip in robotic surgery is a buying moment or a real growth concern?